Please login to the form below

Not currently logged in


This page shows the latest tofacitinib news and features for those working in and with pharma, biotech and healthcare.

Solid Q1 results lift Pfizer as it waits for pipeline boost

Solid Q1 results lift Pfizer as it waits for pipeline boost

Also among the top performers was rheumatoid arthritis drug Xeljanz (tofacitinib), which posted a healthy 30% rise in sales to $423m thanks to new indications in psoriatic arthritis and ulcerative colitis.

Latest news

More from news
Approximately 9 fully matching, plus 53 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change